(19)

(11)

EP 4 561 722 A2

(12)

(88) Date of publication A3: 07.03.2024 (43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23761749.3 (22) Date of filing: 27.07.2023

(51) International Patent Classification (IPC):  B01D 15/12(2006.01) A61K 39/02(2006.01) B01D 61/14(2006.01) B01D 15/38(2006.01) A61K 39/095(2006.01) A61K 35/12(2015.01) (52) Cooperative Patent Classification (CPC): B01D 61/145; B01D 2315/16; A61K 39/095; B01D 15/3847; C12R 2001/36; C12R 2001/01; C07K 14/22; C07K 14/235; C12N 9/1029; C12N 1/20; A61K 39/099; B01D 2315/10; B01D 2311/2697; B01D 2311/08; B01D 2311/2676; A61K 35/74   C-Sets: B01D 15/34, B01D 15/327; (86) International application number: PCT/EP2023/070922 (87) International publication number: WO 2024/023265 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 28.07.2022 GB 202211033 (71) Applicant: GlaxoSmithKline Biologicals S.A. 1330 Rixensart (BE)	(72) Inventors: VANDERCAMMEN, Anne Renée J. 1330 Rixensart (BE) NARDI DEI DA FILICAIA DOTTI, Vincenzo 1330 Rixensart (BE) CHAHIM, Wael 1330 Rixensart (BE) (74) Representative: Brazzini, Silvia  GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG London WC1A 1DG (GB)